Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAstraZeneca studies show relief of nighttime heartburn and reduction in GERD-related sleep disturbances
AstraZeneca, 06/04/09
Two studies from AstraZeneca show that symptomatic gastroesophageal reflux disease patients treated with NEXIUM 20 mg daily experienced greater relief from nighttime heartburn and GERD-related sleep disturbances compared with patients taking placebo over four weeks.1 NEXIUM 20 mg is indicated for the treatment of heartburn and other symptoms associated with GERD. NEXIUM, in a class of drugs called proton pump inhibitors, demonstrated efficacy in relieving moderate-to-severe nighttime heartburn and GERD-related sleep disturbances in two randomized, placebo-controlled trials.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial
Nephrology Dialysis Transplantation, 12/08/09
Today in Major Studies...keeping you current
Receive free subspecialty "5-minute updates" via email
First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
Clinical Pharmacology & Therapeutics, 12/08/09
Amgen Presents Data From First Nplate Study in Children With Chronic ITP
Amgen, 12/08/09
Nplate Data From MDS Studies Presented at ASH
Amgen, 12/07/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Monocarboxylate Transporter (MCT)-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells
Drug Metabolism and Disposition, 12/08/09
Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
American Journal of Health-System Pharmacy, 12/08/09
Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-kB activation to abrogate DSS-induced colitis
Journal of Pharmacology and Experimental Therapeutics, 12/07/09
Sponsor
Article Search
Sponsor